Please login to the form below

Not currently logged in
Email:
Password:

post-operative pain

This page shows the latest post-operative pain news and features for those working in and with pharma, biotech and healthcare.

FDA awards another non-opioid pain drug breakthrough status

FDA awards another non-opioid pain drug breakthrough status

post-operative period. ... The announcement follows a BTD in June for Heron Therapeutics and its HTX-011, also for post-operative pain management.

Latest news

More from news
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    its bupivacaine collagen implant for treatment of post-operative pain. ... Innocoll (US/IE). Gurnet Point (US). Company acquisition. Company with US pre-registration bupivacaine collagen implant for post-operative pain.

  • Grünenthal's relentless pursuit of relief Grünenthal's relentless pursuit of relief

    The need is clear. Seven of the top 50 searches on Patient.info are for pain. ... and pharma product, to treat post-operative pain, and an in-licensed innovative medical sealant for wound closure.

  • Pharma deals in September 2015 Pharma deals in September 2015

    Oncology deals continue to be prominent, but the month also saw CNS-focused deals in vogue; with chronic, post-operative and neuropathic pain centre-stage. ... It is licensed to Grunenthal in Europe. The drug is being evaluated for the treatment of

  • Pharma deals during December 2012 Pharma deals during December 2012

    of a liposomal form of bupivacaine (Exparel) for animal health indications for $1m upfront plus $42.5m in milestones. Exparel was launched for post-surgical pain in the US in April ... an iontophoretic transdermal fentanyl device for treatment of

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Health

Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...